• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Reports of myocarditis in healthy adolescents after Pfizer-BioNTech COVID-19 Vaccination

byAlexa FineandAlex Gipsman, MD
June 9, 2021
in Cardiology, Chronic Disease, Infectious Disease, Pediatrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

 1. In a case series, 7 healthy male adolescents aged 14-19 developed acute myocarditis or myopericarditis within 4 days of receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine.

2. All patients recovered rapidly after treatment with non-steroidal anti-inflammatory (NSAID) medications, intravenous immune globulin, and/or corticosteroids. It is unknown whether these cases are causally linked to vaccination.

Evidence Rating Level: 3 (Average)

Study Rundown: Myocarditis is a rare condition in pediatrics, and is a known but rare side effect of the smallpox vaccine. While the COVID-19 mRNA vaccines have been shown to be safe, less is known about rare safety signals associated with immunization. This case series described seven cases of acute myocarditis or myopericarditis in healthy male adolescents that occurred within four days after vaccination with the second dose of the Pfizer mRNA vaccine. The patients ranged from age 14-19 and all presented with chest pain. Cardiac MRI was diagnostic for myocarditis in all individuals. Other causes of myocarditis were ruled out using nasopharyngeal swabs, serum PCR tests, and infectious serologies. Six patients were treated with NSAIDs, four received intravenous immune globulin and oral prednisone, and one patient additionally received high-dose methylprednisolone. All patients subsequently recovered rapidly. Major limitations of the study include its small sample size and the fact that cases were accrued via communication between colleagues rather than a national database. Overall, the study highlights a possible temporal link between the COVID-19 vaccine and post-immunization myocarditis. This diagnosis should be considered when evaluating adolescents for chest pain following a recent COVID-19 vaccination. This consideration may spare patients from undergoing unnecessary invasive procedures such as cardiac catheterization.

Click to read the study in PEDIATRICS

Relevant Reading: Myocarditis following COVID-19 mRNA vaccination

Image: PD

RELATED REPORTS

Vaccination boosted immunity acquired from previous SARS-CoV-2 infection

Fourth BNT162b2 vaccine dose provides short-term effectiveness against Covid-19 related outcomes

Effectiveness of Covid-19 vaccines waned over timer in North Carolina

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

Tags: covid vaccineMyocarditis
Previous Post

Rapid respiratory pathogen testing does not significantly alter antibiotic prescription rates among children with acute respiratory illness

Next Post

Voclosporin shows clinical promise for treatment of active lupus nephritis

RelatedReports

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

Vaccination boosted immunity acquired from previous SARS-CoV-2 infection

May 13, 2022
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

Fourth BNT162b2 vaccine dose provides short-term effectiveness against Covid-19 related outcomes

May 13, 2022
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

Effectiveness of Covid-19 vaccines waned over timer in North Carolina

March 16, 2022
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

AD26.COV2.S vaccine provides protection against Covid-19

March 7, 2022
Next Post
Multidrug induction therapy increases remission from lupus nephritis

Voclosporin shows clinical promise for treatment of active lupus nephritis

#VisualAbstract: Reduced-dose glucocorticoid adjunct non-inferior to high-dose glucocorticoid plus rituximab regimen for induction of disease remission in autoimmune vasculitis

#VisualAbstract: High-dose methylprednisolone vs. dexamethasone for COVID-19 pneumonia

Quick Take: Effect of intranasal ketamine vs. fentanyl on pain reduction for extremity injuries in children: the PRIME randomized clinical trial

Factors associated with functional impairment after pediatric injury

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Pelvic lymph node radiotherapy and androgen deprivation therapy augment progression-free status following prostatectomy
  • Operating the day after performing surgery the previous night not associated with adverse patient outcomes
  • Gratitude-focused writing may improve mental wellness during periods of chronic stress
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.